BioSpace News Archive

Growing focus on developing alternatives to animal testing is driving revenue growth of the market.

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB) (“Anebulo” or the “Company”), a clinical-stage biotechnology company developing novel solutions for people suffering from cannabinoid intoxication and substance addiction, today reported recent business highlights and announced financial results for the fiscal year 2021 third quarter, ended March 31, 2021.

Adoption of advanced technologies by pharmaceutical companies and hospitals is driving the demand for artificial intelligence in healthcare market.

The advancement in technology and development of therapies and diagnostic solutions is boosting the growth of the Biotechnology Market.

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases announced that the Taiwan market has approved Pemazyre®

Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced it received U.S. Food and Drug Administration (FDA) expanded approval for the Arctic Front™ Family of Cardiac Cryoablation Catheters

The market is estimated to grow with a CAGR of 8.8% from 2020 to 2027.

A computerized brain implant effectively relieves short-term and chronic pain in rodents, a new study finds.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced results from a landmark study investigating how different breast implant surfaces affect the host immune response.

The market is estimated to grow with a CAGR of 9.5% from 2019-2027.